Login / Join
فارما کیان

فارما کیان

Add to Dashboard
Last Transaction-0.98%11,875
Time Period:
سود 3 Months :
پیام‌های فارما کیان
تریدرنوع پیاممنبعزمان انتشارمشاهده پیام
شرکت سرمایه گذاری سپه
شرکت سرمایه گذاری سپه
فروش
tsemcشرکت مدیریت فناوری سازمان بورس
11/19/2025
PRXسبد -شرک 49963- -شرک 15724-
PRXسبد -شرک 49963- -شرک 15724-
خرید
tsemcشرکت مدیریت فناوری سازمان بورس
11/3/2025
شرکت مشاورسرمایه گذاری پرتوآفتاب کیان
شرکت مشاورسرمایه گذاری پرتوآفتاب کیان
خرید
tsemcشرکت مدیریت فناوری سازمان بورس
11/10/2025
PRXسبد -شرک 37608- -شرک 86290-
PRXسبد -شرک 37608- -شرک 86290-
فروش
tsemcشرکت مدیریت فناوری سازمان بورس
11/10/2025
PRXسبد -شرک 49963- -شرک 86290-
PRXسبد -شرک 49963- -شرک 86290-
خرید
tsemcشرکت مدیریت فناوری سازمان بورس
10/19/2025

پیام‌های فارما کیان

Last Update:36 minute ago
Today's Signal Count for فارما کیان:0 Message
شرکت سرمایه گذاری سپه
شرکت سرمایه گذاری سپه
:Sell
Price at Publish Time:
11,921

Sepe Investment Company sold 25.000 million shares of Pharma Kian on 08/28/1404 and currently has 1.68% of shares of Pharma Kian in its stock portfolio.

Translated from: Farsi|
Source Message: Institutional
شرکت سرمایه گذاری سپه
شرکت سرمایه گذاری سپه
:Sell
Price at Publish Time:
11,727

Sepe Investment Company sold 13.000 million shares of Pharma Kian on 19/08/1404 and currently has 2.93% of shares of Pharma Kian in its stock portfolio.

Translated from: Farsi|
Source Message: Institutional
PRXسبد -شرک 37608- -شرک 86290-
PRXسبد -شرک 37608- -شرک 86290-
:Sell
Price at Publish Time:
11,727

PRXSabed -Partner 37608- -Partner 86290- sold 10.694 million shares of PharmaKian on 08/19/1404 and currently has 1.044% of shares of PharmaKian in its stock portfolio.

Translated from: Farsi|
Source Message: Institutional
شرکت مشاورسرمایه گذاری پرتوآفتاب کیان
شرکت مشاورسرمایه گذاری پرتوآفتاب کیان
:Buy
Price at Publish Time:
11,727

Kiyan Sunshine Investment Consulting Company purchased 0.040 million shares of Kiyan Pharma on 08/19/1404 and currently has 2.185% of Kiyan Pharma shares in its stock portfolio.

Translated from: Farsi|
Source Message: Institutional
شرکت مشاورسرمایه گذاری پرتوآفتاب کیان
شرکت مشاورسرمایه گذاری پرتوآفتاب کیان
:Buy
Price at Publish Time:
11,762

Protoaftab Kian Investment Consulting Company purchased 1.159 million shares of Pharma Kian on 08/18/1404 and currently has 2.183% of shares of Pharma Kian in its stock portfolio.

Translated from: Farsi|
Source Message: Institutional
PRXسبد -شرک 37608- -شرک 86290-
PRXسبد -شرک 37608- -شرک 86290-
:Sell
Price at Publish Time:
11,762

PRXSabed -Partner 37608- -Partner 86290- sold 32.743 million shares of PharmaKian on 08/18/1404 and currently has 1.579% of shares of PharmaKian in its stock portfolio.

Translated from: Farsi|
Source Message: Institutional
شرکت مشاورسرمایه گذاری پرتوآفتاب کیان
شرکت مشاورسرمایه گذاری پرتوآفتاب کیان
:Buy
Price at Publish Time:
12,117

Kiyan Sunshine Investment Consulting Company purchased 0.575 million shares of Kiyan Pharma on 08/17/1404 and currently has 2.125% of Kiyan Pharma shares in its stock portfolio.

Translated from: Farsi|
Source Message: Institutional
PRXسبد -شرک 37608- -شرک 86290-
PRXسبد -شرک 37608- -شرک 86290-
:Sell
Price at Publish Time:
12,117

PRXbasket -Partner 37608- -Partner 86290- sold 3.899 million shares of Pharma Kayan on 08/17/1404 and currently has 3.216% of shares of Pharma Kayan in its stock portfolio.

Translated from: Farsi|
Source Message: Institutional
شرکت مشاورسرمایه گذاری پرتوآفتاب کیان
شرکت مشاورسرمایه گذاری پرتوآفتاب کیان
:Buy
Price at Publish Time:
12,124

Kiyan Sunshine Investment Consulting Company purchased 0.505 million shares of Kiyan Pharma on 08/14/1404 and currently has 2.096% of Kiyan Pharma shares in its stock portfolio.

Translated from: Farsi|
Source Message: Institutional
PRXسبد -شرک 37608- -شرک 86290-
PRXسبد -شرک 37608- -شرک 86290-
:Sell
Price at Publish Time:
12,124

PRXSabed - 37608 Shares - 86290 Shares - sold 3.393 million shares of Pharma Kayan on 08/14/1404 and currently has 3.411% of shares of Pharma Kayan in its stock portfolio.

Translated from: Farsi|
Source Message: Institutional
Disclaimer

Any content and materials included in Sahmeto's website and official communication channels are a compilation of personal opinions and analyses and are not binding. They do not constitute any recommendation for buying, selling, entering or exiting the stock market and cryptocurrency market. Also, all news and analyses included in the website and channels are merely republished information from official and unofficial domestic and foreign sources, and it is obvious that users of the said content are responsible for following up and ensuring the authenticity and accuracy of the materials. Therefore, while disclaiming responsibility, it is declared that the responsibility for any decision-making, action, and potential profit and loss in the capital market and cryptocurrency market lies with the trader.

Signals
Top Traders
Feed
Alerts